Adeseye Lasekan, PhD’s Post

View profile for Adeseye Lasekan, PhD, graphic

Senior Food Scientist I Food Innovation and Sustainability Advocate I Sharing insights and perspectives on the latest trends and developments in the food industry I I help connect industry solutions to consumer needs |

I wish Upside have crafted a response that is not just for Bloomberg and the scientific communities that may understand (to some extent) some of the technical terms that are used to describe their product. Unfortunately, some of these terms were even difficult for me to wrap my head around and I imagine the struggle of an average consumer who has never been to a cell culture lab to understand these key phrases. Without trying to court any controversy, I would love to have experts in the field help explain/define these terms from the article: suspension product, delicious blended cultivated meat products, suspension chicken, cultivated chicken (made from our small scale tissue process), and delicious suspension products. In a world, where we all go to the store to buy "chicken", would there be a time when we start saying "hey, get me some suspension chicken from Walmart". This category needs a better messaging strategy.

View profile for Elaine Watson, graphic

Global food tech editor, AgFunderNews (AFN)

UPSIDE Foods responds to the recent Bloomberg article (https://lnkd.in/gtszKEFy)... "The most glaring omission from the article is the tremendous progress we have made towards commercial scale, including the critical role of large-scale “suspension” products in our strategy. "The article concludes that the industry, and UPSIDE specifically, does not have a path to scale its product and has “little to show for itself.” This is inaccurate and is a dated snapshot of our progress from several years ago. Bloomberg ignored our repeated requests stating that our tissue product is not slated for scaling near-term and that we are instead focused on first commercializing our suspension product, which produces delicious blended cultivated meat products. "This suspension product was the basis for our Series C fundraise, has been proven out through dozens of successful runs in our 2kL cultivators at EPIC, and is the design basis for our commercial scale processes. "We told Bloomberg we produced enough cells in a single cultivator in the last month to produce the equivalent of over 2,000 pounds of delicious finished chicken products. They did not print that and instead focused on the small quantities of the chicken we currently have on the market (our “tissue” product)." #foodtech #cultivatedmeat #cellularagriculture

UPSIDE Foods | Our Response to Recent Press

UPSIDE Foods | Our Response to Recent Press

upsidefoods.com

To view or add a comment, sign in

Explore topics